|Title:||Differential Analgesic Effects of Tenoxicam on the Wound Pain and Uterine Cramping Pain after Cesarean Section||Authors:||HSU, HSING-WEN
CHEN, LI- KUEI
|Keywords:||Cesarean section;Morphine;Patient-controlled analgesia;Tenoxicam||Issue Date:||2003||Journal Volume:||v.19||Journal Issue:||n.1||Start page/Pages:||55-58||Source:||CLINICAL JOURNAL OF PAIN||Abstract:||
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to enhance opioid analgesia in the acute pain service. The question, however, of whether NSAIDs produce a similar extent of potentiation among different types of pain, has not been thoroughly investigated. Materials and Methods: A randomized, placebo-controlled, double-blind study was performed to characterize the analgesic effect of tenoxicam, a long-acting NSAID, on resting wound pain, evoked wound pain, and uterine cramping pain after cesarean section. Saline (n = 48) or 20 mg tenoxicam (n = 45) was intravenously injected immediately after clamping the umbilical cord. All patients were instructed to obtain maximal postoperative analgesia by intravenous patient-controlled morphine. Results: Tenoxicam profoundly reduced the intensity of uterine cramping pain (3 .6 [2.0-5.6] versus 5.5 [3.4-6.6];p < 0.01) but had no additional effect on wound pain at rest, with movement, changing position, sitting, and walking. Intraoperative injection of 20 mg tenoxicam decreased the demand ratio for patient- controlled analgesia (PCA) and 24-hour morphine consumption by approximately 30%. Conclusions: The data show that tenoxicam potentiates opioid analgesic effect on the somatic and visceral types of pain to different extents, and they suggest that intraoperative injection of 20 mg tenoxicam is sufficient to enhance intravenous PCA morphine on uterine cramping pain for the first 24 hours after cesarean section.
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.